As long as share prices go up, don't care who is the partner. LOL

I queue at 0.17.....wait long .......long .....long.. also cannot get

I got a funny feeling this PP is related to new Chairman

@hanzo, pls continue to make your money at other counters.....don't disturb baby sleeping. Bye2

Kling Kling.....yr Vaccine is here...Kling Kling

Those bikes selling ice cream will be in big demand. LOL

Ok la...no lose money

NPRA, you sold at .18 or .16?

Good...now get ready to takeoff

angelo..market very red. If finished unchanged already good liao.

Joining Covax means China is supplying its vaccine to WHO, yes?

Today market don't know why very bad. Bursa must have got up wrong side of bed. LOL

Let's take a break from Vaccine for a while.
The following is an extract taken from Chairman report in Kanger Annual Report 2019 of what they actually do. Interesting read to know what we are investing into.
----------------------------------------------------------------------------------------------------------------------------


PERFORMANCE OVERVIEW

FYE 2019 was a trying year. The challenges we faced were many, but fortunately, our achievements were no less so. In the face of rising US-China trade tensions, a softening Chinese economy and political upheaval in Hong Kong, I am pleased to report that the Group successfully returned to profitability on an after-tax basis, a significant accomplishment in itself.
Net profit of RM9.39 million was recorded, compared to a net loss of RM1.71 million (including discontinued operations) in financial year ended 31 December 2018.

Despite China’s economic growth moderating further to 6.1% in 2019 from 6.6% in 2018, our Group remains resilient and delivered total revenues of RM65.0 million, an increase of 9.8% from RM59.2 million in the previous financial year.

With the strategic relocation of our bamboo processing and manufacturing operations from Ganzhou to Jingzhou still ongoing, this commendable result can largely be attributed to our decision in 2018 to secure the exclusive distributorship in China for the “CLASSEN” brand of laminated hardwood flooring from Classen GmbH, Germany.

Had both revenue streams been up and running during FYE 2019 (in-house and third party products), our results would have been even more impressive. Nevertheless, this is something we can eagerly look forward to in the coming financial year, as manufacturing and sales of our own bamboo-based products, this time from an expanded new base in Jingzhou, will have re-commenced. The Jingzhou operations would be further bolstered by having our own fully matured bamboo plantation concession for the first time in our Group’s history.

NOTABLE ACHIEVEMENTS

Over the past year, the Group has continued to focus and expend great effort on putting itself on a much stronger financial footing. These efforts have culminated in the construction and recent completion of our two commercial buildings in the Ganzhou Economic & Technological Development Zone, Jiangxi Province, People’s Republic of China by our indirect
wholly-owned subsidiary, Ganzhou Kanger Industrial Co. Ltd.

In Jingzhou City, Hubei Province we are also in the final stages of completing our new high-tech bamboo processing/ manufacturing plant and R&D centre. The main factory buildings were completed in early-March 2020 and the relevant machinery are being installed and commissioned. Once production goes into full swing, bamboo flooring and intermediate
products will once again be a major revenue and earnings contributor to our Group.

22 KANGER INTERNATIONAL BERHAD ANNUAL REPORT 2019

In short, various business and operational milestones were achieved in FYE 2019 with regards to our main pillars of revenue, including the expansion of our sales network. Further details on our operations are given in the Management Discussion and Analysis section of this Annual Report.

Here, I would just like to highlight several major achievements as at the date of this Annual Report:

1. We added the 107th sales outlet to our continuously growing dealer network, which now spans numerous key provinces in China such as Fujian, Guangdong, Sichuan, Hunan, Hebei, Jiangsu and Yunan, as well as major economic centres like Shanghai, Beijing and Hangzhou.

2. We completed and handed over our two newly-constructed commercial buildings in the Ganzhou Economic and Technological Development Zone, with a combined net lettable area of 683,777 sq. ft., to our tenants for final renovation and fit-out works, while signing separate 10-year lease agreements for each of the buildings. This marks a significant milestone in our quest to establish a stable and recurring income base for the Group. The initial combined rental income amounts to approximately RM11.1 million per annum based on current exchange rates. This will grow further in later years with the scheduled rent increases in the agreements.

3. We completed construction of the three main factory buildings at our Jingzhou bamboo processing and manufacturing plant and high-tech R&D centre. In the process, we also fulfilled the first key performance benchmark which entitled us to receive the equivalent of RM5.2 million from the Jingzhou local authority.

This is only the first of a series of earnouts provided for under a multi-year incentives programme agreed with the government. As at the date of this Annual Report, the relevant machinery for the factories is being installed for trial production targeted around mid-2020.

I think it is a transfer

When is Cansino announcing its testing results? Is it ready yet? Sinopharm, Pfizer, Moderna had announced their efficacy already.

Given Wu's profile, age and working experience, I am not surprised he is acting for someone else. He was appointed late 2019 as director. Don't think he is involved on day to day operations.

90m already sold and absorbed liao

Scared today go back to original price before glove project announcement.

So far Pfizer, Moderna, Bion Tec and Sinopharm had announce their efficacy. What's happening to Sinovac, Cansino and the rest?

Vaccine news keep coming out daily. This bring high awareness in vaccine counters.

Rising sea tide will lift all boats ( I mean vaccine boats)

And I gong gong sit and wait

Looks like today closing likely be .180

All valid vaccines will be winners in this pandemic.

Sure win situation...I am just assessing risk

One way or another, Sinopharm will be one of them.

This is the 2nd time I hear from KJ that he mentioned non disclosure documents, no wonder we do not hear any news from Kanger.

This share is like caterpillar. Move very slowly. But it will soon be a butterfly. So to see good things have to wait la.

Government most likely will buy few brands to spread out risks of any side effects that can happen to all levels of population. It is matter of who get more share or less unless the vaccine is not approved at all.

I still queuing at 170. No hurry ..can wait.

BEIJING- Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and Prevention (CDC) said.

Read more at:
https://economictimes.indiatimes.com/news/international/world-news/china-coronavirus-vaccine-may-be-ready-for-public-in-november-official/articleshow/78119754.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

Khairy in Parliment on vaccine

https://www.youtube.com/watch?v=-iImSD318ac&feature=youtu.be

Moment of truth is fast approaching. Who got vaccine, who don't have vaccine.

Even Ruler of UAE get Sinopharm vaccine. So is it halal or not?

https://www.bloomberg.com/news/articles/2020-11-03/dubai-ruler-gets-covid-vaccine-joining-other-top-uae-officials

Maybe oskchoon think -70 deg freezer is good for gloves. Scared gloves might melt. LOL

Ignorance is entertaining these days ..lol

Looks like my .165 buy have to revise liao.

Today...gunung merapi akan meletup...hehehehe

First Australian vacicnated with Sinopharm
---------------------------------------------------------
But the fact is, there are many vaccines out there in the world being tested for the final release. Rochelle received one of them – the one that's made by a Chinese company Sinopharm.

"The fear of getting the virus outweighed the fear of having the vaccination," she explained her intention of getting vaccinated to 9News.

The Sinopharm vaccine is now being tested in the UAE, with 30,000 people injected, including the country's prime minister.


https://news.cgtn.com/news/2020-11-15/First-Aussie-vaccinated-against-COVID-19-confuses-local-authorities-VrHGOv9yW4/index.html

Tomorrow if can get .165, I be very happy already.

https://www.malaymail.com/news/money/2020/06/24/kanger-legasi-lestari-team-up-to-export-river-sand-to-china-hong-kong/1878550

Legasi Lestari partly owned by the family of the former Pahang State Assembly Speaker who passed on few years ago.

One of its director is Professor Datuk Seri Md Zabid was formerly Chairman of Unitar (University Tun Abd Razak) and Lestari Legacy its jv partner for sand concession is a Pekan based company.

This low profile counter is not simple

Syed Razlan Ibni Syed Putra - Prince of Perlis Royalty

Mad..Tuanku Syed Sirajuddin ibni Almarhum Tuanku Syed Putra Jamalullail, I believe he is Perlis Sultan

Surprised to see this name appear as Kanger shareholder

Syed Sirajuddin Putra Jamalullail & Syed Razlan Ibni Syed Putra

Next week is the last call.

Certification of a fill and finish facility to meet manufacturer standard take a long time.

There are bound to be politics involved but none bigger than the urgent need for vaccine. I personally don't see much hindrance to it. What is holding back would be the imminent release of data and smooth full production phase post third phase.

It reminds me of early inventors who make such great machines in their research centers but not feasible or practical in the real world.